<DOC>
	<DOCNO>NCT00003206</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy use different way stop tumor cell divide stop grow die . PURPOSE : Phase II trial study effectiveness carboplatin paclitaxel treat patient locally recurrent metastatic nasopharyngeal cancer .</brief_summary>
	<brief_title>Carboplatin Paclitaxel Treating Patients With Locally Recurrent Metastatic Nasopharyngeal Cancer</brief_title>
	<detailed_description>OBJECTIVES : I . Estimate response toxicity carboplatin combination paclitaxel patient locally recurrent metastatic nasopharyngeal carcinoma . OUTLINE : Patients receive paclitaxel IV 3 hour follow carboplatin IV 30 minute . This cycle repeat every 3 week . Patients may receive 6-8 cycle therapy absence toxicity disease progression . Patients follow every 3 month first 2 year , every 6 month next 3 year , yearly thereafter . PROJECTED ACCRUAL : 30 eligible patient accrue approximately 18 month .</detailed_description>
	<mesh_term>Head Neck Neoplasms</mesh_term>
	<mesh_term>Nasopharyngeal Neoplasms</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<mesh_term>Carboplatin</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm locally recurrent metastatic nasopharyngeal carcinoma curable resection radiation therapy Bidimensionally measurable disease PATIENT CHARACTERISTICS : Age : 18 Performance status : ECOG 01 Life expectancy : Not specify Hematopoietic : Absolute neutrophil count great 1500/mm3 Platelet count great 100,000/mm3 Hepatic : Bilirubin le 1.5 mg/dL Renal : Creatinine le 3.0 mg/dL Other : No active infection Serum calcium within institutional normal range No history hypercalcemia Prior malignancy nasopharyngeal carcinoma allow No concurrent malignancy Not pregnant lactate Fertile patient must use effective contraception PRIOR CONCURRENT THERAPY : Biologic therapy : Prior biologic therapy allow Chemotherapy : No prior chemotherapy metastatic recurrent disease Prior induction adjuvant chemotherapy concurrent radiation therapy allow No prior treatment paclitaxel Endocrine therapy : Not specify Radiotherapy : See Chemotherapy Surgery : Not specify</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2013</verification_date>
	<keyword>stage IV nasopharyngeal cancer</keyword>
	<keyword>recurrent nasopharyngeal cancer</keyword>
</DOC>